Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

Private Advisor Group LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing ...

Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical devices. Sales were also higher at its pharmaceutical unit, but fell at its diagnostics and ...

Investors happily greeted the latest news from Abbott Laboratories (NYSE: ABT) on Hump Day. After the storied healthcare company unveiled its third-quarter results, those folks traded its stock up ...

Abbott Laboratories (NYSE:ABT) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table ...

Trilogy Capital Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 5.6% in the third quarter, ...

For Abbott Laboratories, the 200-day moving average sits at $110.38, according to Benzinga Pro, which is below the current price of $117.31. For more on charts and trend lines, see a description here.

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories (NYSE: ABT). Abbott is a longtime leader in the ...